1. Home
  2. Africa
  • News

Drug giant backs kiddie AIDS care

US drug giant Bristol-Myers Squibb (BMS) said on Wednesday it would deploy 50 paediatric doctors to sub-Saharan Africa each year for the next five years as part of efforts to treat HIV-positive children.

The announcement followed concerns raised by former US President Bill Clinton during the International AIDS Conference in Toronto, Canada, over children falling through the cracks when it came to the availability of child-friendly anti-AIDS drugs in developing countries.

According to a BMS statement, doctors will start arriving next Monday to kick off the first phase of the campaign, which covers prevention of mother-to-child transmission of HIV. They will be based at children's clinical centres in Botswana, Lesotho, Malawi, Swaziland, Uganda and Burkina Faso.

UNAIDS estimates that Sub-Saharan Africa is home to 90 percent of the 2.3 million children living with the HI virus globally, but fewer than 10 percent are being reached by basic anti-AIDS care services.


This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article

Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join